#United States #Deloitte #Sunnyvale #Synopsys #Peter Shimer

Synopsys Welcomes Peter Shimer to Its Leadership Team

In a landmark announcement, Synopsys, Inc. has appointed Peter A. Shimer to its board of directors. This strategic move brings a wealth of experience from the financial and consulting sectors, especially from his illustrious career at Deloitte, where he spent four decades honing his skills and expertise.

Peter Shimer's Career Highlights

Peter Shimer is renowned for his extensive background at Deloitte, where he adapted to several executive roles, eventually serving as the interim CEO. Under his leadership, Deloitte saw remarkable growth—annual revenues surged by over 135%, reaching an impressive $30 billion. His proficiency in navigating complex business challenges and advising executive teams is well recognized, making him a coveted addition to Synopsys’s board.

In addition to his role at Synopsys, Shimer serves as the executive committee chair of the Cancer Artificial Intelligence Alliance (CAIA). This consortium, which includes leading academic medical institutions, aims to revolutionize cancer research and clinical outcomes through advancements in AI technology.

His role at Deloitte saw him spearheading significant strategic initiatives, including the enhancement of Deloitte University and the global implementation of the company's enterprise resource planning (ERP) system. Moreover, his contributions included driving operational performance improvements, solidifying the firm's standing in the competitive market.

Synopsys’s Future Direction

The appointment follows a clear intention by Synopsys to refresh its board and embrace innovative leadership as it journeys deeper into the technology sector. Sassine Ghazi, the company’s president and CEO, expressed confidence that Shimer would significantly contribute to Synopsys's mission to empower engineers with groundbreaking solutions that facilitate the design and delivery of AI-powered products from silicon to systems.

Shimer's enthusiasm about his new role resonates with the company's vision. He shared his excitement regarding Synopsys's potential to provide top-tier solutions that drive modern innovation, underscoring the increasing demand for cutting-edge, software-defined, and AI-enhanced systems across various industries.

Ongoing Board Transitions

As part of this strategic restructuring, Synopsys also announced that Luis Borgen and Dr. Ajei Gopal will not be renominated for re-election at the upcoming annual stockholders' meeting in 2026. This decision reflects the board's commitment to renewal while maintaining essential continuity. Both Borgen and Gopal will continue to serve until the annual meeting, marking a seamless transition amid changes.

Aart de Geus, executive chair and Synopsys founder, acknowledged the significant contributions of the outgoing board members, referring to their leadership as instrumental in positioning Synopsys as a frontrunner in the silicon-to-systems engineering market.

About Synopsys

Synopsys, Inc. (NASDAQ: SNPS) stands as a leader in engineering solutions, offering innovative products and services that enable its clients to efficiently design cutting-edge, AI-powered technologies. With a strong focus on advancing engineering capabilities across a diverse range of industries, Synopsys continues to be at the forefront of innovation, ensuring a bright future for technological advancements. For more information about Synopsys and its offerings, visit www.synopsys.com.